Skip to main content

Not investment advice.Read full disclaimer

SABS: SAB Biotherapeutics, Inc. Company Profile & Overview | finqOS

Healthcare · Biotechnology

52W Range

34thpctl

Volume

0.07×avg

Market Cap

31.74MUSD

P/E Ratio

-447.6TTM

Div Yield

-ann

Continue with finqOS

Get the full profile on SAB Biotherapeutics, Inc.

Executive team, business description, key stats, and everything you need to understand the company.

Start Free Trial→Sign In

14-day free trial · No credit card required

SAB Biotherapeutics, Inc.

SABSNASDAQ Global Market·USD·Closed

SAB Biotherapeutics, Inc.

SABSNASDAQ·USD·Closed

$3.32

−4.29%

$3.32

−$0.15 (4.29%)

52W Range

34thpctl

Volume

0.07×avg

Mkt Cap

31.74MUSD

P/E

-447.6TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings